<DOC>
	<DOCNO>NCT02811315</DOCNO>
	<brief_summary>The objective study evaluate effect frequency use spacer asthma control Dutch patient asthma daily clinical practice 12 week treatment .</brief_summary>
	<brief_title>Flutiform Treatment Patients With Asthma Daily Clinical Practice .</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Patients eligible prescribed fluticasone/formoterol fix dose combination follow : Patients adequately control inhaled corticosteriods `` require '' inhale short act beta 2 agonist patient already adequately control inhaled corticosteriod longacting beta 2 agonist . The decision prescribe fluticasone/formoterol fix dose combination precede independent decision enroll patient study There specific exclusion criterion observational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>